Cholera deaths rise in South Sudan amid aid cuts
In a devastating turn of events, eight people—five of them children—have died from cholera in South Sudan’s eastern Jonglei state. The heartbreaking news comes as [more…]
Category: U.S.
FDA pulls the plug on Red No. 3 dye after cancer concerns
The cherry-red glow of candies, cereals, and milkshakes will soon fade as the FDA drops the curtain on Red No. 3. This synthetic dye, long [more…]
McDonald’s Quarter Pounder pulled amid E. Coli outbreak
It seems like McDonald’s is in the frying pan again—this time, not for their burgers but for what’s possibly lurking in them. Late last week, [more…]
Novo Nordisk’s Wegovy approved in China, faces patent challenges and competition
Novo Nordisk’s weight-loss drug Wegovy has received the green light in China, targeting the world’s second-largest economy and the country with the highest number of [more…]
Celltrion celebrates U.S. launch of Zymfentra, offering patients new hope
Celltrion, the pioneering Korean biopharmaceuticals firm, has made a significant stride in the US market with the launch of its groundbreaking autoimmune disease treatment, Zymfentra. [more…]
Opill, the first over-the-counter oral contraceptive, hits shelves in the U.S.
The arrival of Opill, the first over-the-counter oral contraceptive in the United States, marks a significant milestone in reproductive health accessibility. With a manufacturer’s suggested [more…]
Viking Therapeutics’ VK2735 demonstrates promising results in weight loss
Viking Therapeutics surged approximately 80% on Tuesday following the announcement of promising results from its mid-stage trial of an experimental weight loss drug. The drug, [more…]
Eisai’s Alzheimer’s drug Leqembi set for China rollout
Eisai plans to introduce its groundbreaking Alzheimer’s drug, Leqembi, to 1,500 people in China this year, with expectations of significant growth in 2025 as diagnosis [more…]
FDA grants groundbreaking approval for Casgevy, a revolutionary gene-editing treatment for sickle cell disease
In a monumental stride forward in medical science, the U.S. Food and Drug Administration (FDA) has granted approval for the first gene-editing treatment for sickle [more…]
FDA approval of Tirzepatide opens new avenues for obesity treatment
In a groundbreaking development, the Food and Drug Administration (FDA) has granted approval to Eli Lilly’s blockbuster drug, tirzepatide, for the treatment of obesity in [more…]
